Global Cancer Immunotherapies Market Research Report 2020

Publisher Name :
Date: 11-Nov-2020
No. of pages: 117
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Cancer Immunotherapies market is segmented into

- Monoclonal Antibodies (MABs)

- Cancer Vaccines

- Immunomodulators

- Adoptive Cell transfer

- Checkpoint Inhibitors

Segment by Application

- Breast Cancer

- Leukemia

- Lymphoma

- Melanoma

- Colorectal Cancer

- Non-Small Cell Lung Cancer

Global Cancer Immunotherapies Market: Regional Analysis

The Cancer Immunotherapies market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Cancer Immunotherapies market report are:

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Cancer Immunotherapies Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Cancer Immunotherapies market include:

- Amgen

- AstraZeneca

- Roche

- Bristol-Myers Squibb

- Bayer

- Merck

- ARMO BioSciences (Eli Lilly)

- Novartis

- Pfizer

- Johnson & Johnson

- AbbVie

- Gilead Sciences

Global Cancer Immunotherapies Market Research Report 2020

Table of Contents
1 Cancer Immunotherapies Market Overview
1.1 Product Overview and Scope of Cancer Immunotherapies
1.2 Cancer Immunotherapies Segment by Type
1.2.1 Global Cancer Immunotherapies Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Cancer Vaccines
1.2.4 Immunomodulators
1.2.5 Adoptive Cell transfer
1.2.6 Checkpoint Inhibitors
1.3 Cancer Immunotherapies Segment by Application
1.3.1 Cancer Immunotherapies Sales Comparison by Application: 2020 VS 2026
1.3.2 Breast Cancer
1.3.3 Leukemia
1.3.4 Lymphoma
1.3.5 Melanoma
1.3.6 Colorectal Cancer
1.3.7 Non-Small Cell Lung Cancer
1.4 Global Cancer Immunotherapies Market Size Estimates and Forecasts
1.4.1 Global Cancer Immunotherapies Revenue 2015-2026
1.4.2 Global Cancer Immunotherapies Sales 2015-2026
1.4.3 Cancer Immunotherapies Market Size by Region: 2020 Versus 2026
1.5 Cancer Immunotherapies Industry
1.6 Cancer Immunotherapies Market Trends
2 Global Cancer Immunotherapies Market Competition by Manufacturers
2.1 Global Cancer Immunotherapies Sales Market Share by Manufacturers (2015-2020)
2.2 Global Cancer Immunotherapies Revenue Share by Manufacturers (2015-2020)
2.3 Global Cancer Immunotherapies Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Cancer Immunotherapies Manufacturing Sites, Area Served, Product Type
2.5 Cancer Immunotherapies Market Competitive Situation and Trends
2.5.1 Cancer Immunotherapies Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Cancer Immunotherapies Players (Opinion Leaders)
3 Cancer Immunotherapies Retrospective Market Scenario by Region
3.1 Global Cancer Immunotherapies Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Cancer Immunotherapies Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Cancer Immunotherapies Market Facts & Figures by Country
3.3.1 North America Cancer Immunotherapies Sales by Country
3.3.2 North America Cancer Immunotherapies Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cancer Immunotherapies Market Facts & Figures by Country
3.4.1 Europe Cancer Immunotherapies Sales by Country
3.4.2 Europe Cancer Immunotherapies Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cancer Immunotherapies Market Facts & Figures by Region
3.5.1 Asia Pacific Cancer Immunotherapies Sales by Region
3.5.2 Asia Pacific Cancer Immunotherapies Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cancer Immunotherapies Market Facts & Figures by Country
3.6.1 Latin America Cancer Immunotherapies Sales by Country
3.6.2 Latin America Cancer Immunotherapies Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Cancer Immunotherapies Market Facts & Figures by Country
3.7.1 Middle East and Africa Cancer Immunotherapies Sales by Country
3.7.2 Middle East and Africa Cancer Immunotherapies Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Cancer Immunotherapies Historic Market Analysis by Type
4.1 Global Cancer Immunotherapies Sales Market Share by Type (2015-2020)
4.2 Global Cancer Immunotherapies Revenue Market Share by Type (2015-2020)
4.3 Global Cancer Immunotherapies Price Market Share by Type (2015-2020)
4.4 Global Cancer Immunotherapies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Cancer Immunotherapies Historic Market Analysis by Application
5.1 Global Cancer Immunotherapies Sales Market Share by Application (2015-2020)
5.2 Global Cancer Immunotherapies Revenue Market Share by Application (2015-2020)
5.3 Global Cancer Immunotherapies Price by Application (2015-2020)
6 Company Profiles and Key Figures in Cancer Immunotherapies Business
6.1 Amgen
6.1.1 Corporation Information
6.1.2 Amgen Description, Business Overview and Total Revenue
6.1.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Amgen Products Offered
6.1.5 Amgen Recent Development
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description, Business Overview and Total Revenue
6.2.3 AstraZeneca Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.2.4 AstraZeneca Products Offered
6.2.5 AstraZeneca Recent Development
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description, Business Overview and Total Revenue
6.3.3 Roche Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Roche Products Offered
6.3.5 Roche Recent Development
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bristol-Myers Squibb Products Offered
6.4.5 Bristol-Myers Squibb Recent Development
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description, Business Overview and Total Revenue
6.5.3 Bayer Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bayer Products Offered
6.5.5 Bayer Recent Development
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description, Business Overview and Total Revenue
6.6.3 Merck Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Merck Products Offered
6.6.5 Merck Recent Development
6.7 ARMO BioSciences (Eli Lilly)
6.6.1 ARMO BioSciences (Eli Lilly) Corporation Information
6.6.2 ARMO BioSciences (Eli Lilly) Description, Business Overview and Total Revenue
6.6.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.4.4 ARMO BioSciences (Eli Lilly) Products Offered
6.7.5 ARMO BioSciences (Eli Lilly) Recent Development
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description, Business Overview and Total Revenue
6.8.3 Novartis Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Novartis Products Offered
6.8.5 Novartis Recent Development
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description, Business Overview and Total Revenue
6.9.3 Pfizer Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Pfizer Products Offered
6.9.5 Pfizer Recent Development
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Johnson & Johnson Products Offered
6.10.5 Johnson & Johnson Recent Development
6.11 AbbVie
6.11.1 AbbVie Corporation Information
6.11.2 AbbVie Cancer Immunotherapies Description, Business Overview and Total Revenue
6.11.3 AbbVie Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.11.4 AbbVie Products Offered
6.11.5 AbbVie Recent Development
6.12 Gilead Sciences
6.12.1 Gilead Sciences Corporation Information
6.12.2 Gilead Sciences Cancer Immunotherapies Description, Business Overview and Total Revenue
6.12.3 Gilead Sciences Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Gilead Sciences Products Offered
6.12.5 Gilead Sciences Recent Development
7 Cancer Immunotherapies Manufacturing Cost Analysis
7.1 Cancer Immunotherapies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cancer Immunotherapies
7.4 Cancer Immunotherapies Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cancer Immunotherapies Distributors List
8.3 Cancer Immunotherapies Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Cancer Immunotherapies Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cancer Immunotherapies by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Cancer Immunotherapies by Type (2021-2026)
10.2 Cancer Immunotherapies Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cancer Immunotherapies by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Cancer Immunotherapies by Application (2021-2026)
10.3 Cancer Immunotherapies Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cancer Immunotherapies by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Cancer Immunotherapies by Region (2021-2026)
10.4 North America Cancer Immunotherapies Estimates and Projections (2021-2026)
10.5 Europe Cancer Immunotherapies Estimates and Projections (2021-2026)
10.6 Asia Pacific Cancer Immunotherapies Estimates and Projections (2021-2026)
10.7 Latin America Cancer Immunotherapies Estimates and Projections (2021-2026)
10.8 Middle East and Africa Cancer Immunotherapies Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Cancer Immunotherapies Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Cancer Immunotherapies Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Cancer Immunotherapies Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Cancer Immunotherapies Manufacturers Covered in This Study
Table 5. Global Cancer Immunotherapies Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Cancer Immunotherapies Sales Share by Manufacturers (2015-2020)
Table 7. Global Cancer Immunotherapies Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Cancer Immunotherapies Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Cancer Immunotherapies Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Cancer Immunotherapies Sales Sites and Area Served
Table 11. Manufacturers Cancer Immunotherapies Product Types
Table 12. Global Cancer Immunotherapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cancer Immunotherapies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapies as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Cancer Immunotherapies Players
Table 16. Global Cancer Immunotherapies Sales (K Units) by Region (2015-2020)
Table 17. Global Cancer Immunotherapies Sales Market Share by Region (2015-2020)
Table 18. Global Cancer Immunotherapies Revenue (Million US$) by Region (2015-2020)
Table 19. Global Cancer Immunotherapies Revenue Market Share by Region (2015-2020)
Table 20. North America Cancer Immunotherapies Sales by Country (2015-2020) (K Units)
Table 21. North America Cancer Immunotherapies Sales Market Share by Country (2015-2020)
Table 22. North America Cancer Immunotherapies Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Cancer Immunotherapies Revenue Market Share by Country (2015-2020)
Table 24. Europe Cancer Immunotherapies Sales by Country (2015-2020) (K Units)
Table 25. Europe Cancer Immunotherapies Sales Market Share by Country (2015-2020)
Table 26. Europe Cancer Immunotherapies Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Cancer Immunotherapies Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Cancer Immunotherapies Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Cancer Immunotherapies Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Cancer Immunotherapies Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Cancer Immunotherapies Revenue Market Share by Region (2015-2020)
Table 32. Latin America Cancer Immunotherapies Sales by Country (2015-2020) (K Units)
Table 33. Latin America Cancer Immunotherapies Sales Market Share by Country (2015-2020)
Table 34. Latin America Cancer Immunotherapies Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Cancer Immunotherapies Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Cancer Immunotherapies Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Cancer Immunotherapies Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Cancer Immunotherapies Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Cancer Immunotherapies Revenue Market Share by Country (2015-2020)
Table 40. Global Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 41. Global Cancer Immunotherapies Sales Share by Type (2015-2020)
Table 42. Global Cancer Immunotherapies Revenue (Million US$) by Type (2015-2020)
Table 43. Global Cancer Immunotherapies Revenue Share by Type (2015-2020)
Table 44. Global Cancer Immunotherapies Price (USD/Unit) by Type (2015-2020)
Table 45. Global Cancer Immunotherapies Sales (K Units) by Application (2015-2020)
Table 46. Global Cancer Immunotherapies Sales Market Share by Application (2015-2020)
Table 47. Global Cancer Immunotherapies Sales Growth Rate by Application (2015-2020)
Table 48. Amgen Cancer Immunotherapies Corporation Information
Table 49. Amgen Description and Business Overview
Table 50. Amgen Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Amgen Main Product
Table 52. Amgen Recent Development
Table 53. AstraZeneca Cancer Immunotherapies Corporation Information
Table 54. AstraZeneca Corporation Information
Table 55. AstraZeneca Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. AstraZeneca Main Product
Table 57. AstraZeneca Recent Development
Table 58. Roche Cancer Immunotherapies Corporation Information
Table 59. Roche Corporation Information
Table 60. Roche Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Roche Main Product
Table 62. Roche Recent Development
Table 63. Bristol-Myers Squibb Cancer Immunotherapies Corporation Information
Table 64. Bristol-Myers Squibb Corporation Information
Table 65. Bristol-Myers Squibb Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Bristol-Myers Squibb Main Product
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Bayer Cancer Immunotherapies Corporation Information
Table 69. Bayer Corporation Information
Table 70. Bayer Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Bayer Main Product
Table 72. Bayer Recent Development
Table 73. Merck Cancer Immunotherapies Corporation Information
Table 74. Merck Corporation Information
Table 75. Merck Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Merck Main Product
Table 77. Merck Recent Development
Table 78. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Corporation Information
Table 79. ARMO BioSciences (Eli Lilly) Corporation Information
Table 80. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. ARMO BioSciences (Eli Lilly) Main Product
Table 82. ARMO BioSciences (Eli Lilly) Recent Development
Table 83. Novartis Cancer Immunotherapies Corporation Information
Table 84. Novartis Corporation Information
Table 85. Novartis Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Novartis Main Product
Table 87. Novartis Recent Development
Table 88. Pfizer Cancer Immunotherapies Corporation Information
Table 89. Pfizer Corporation Information
Table 90. Pfizer Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Pfizer Main Product
Table 92. Pfizer Recent Development
Table 93. Johnson & Johnson Cancer Immunotherapies Corporation Information
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Johnson & Johnson Main Product
Table 97. Johnson & Johnson Recent Development
Table 98. AbbVie Cancer Immunotherapies Corporation Information
Table 99. AbbVie Corporation Information
Table 100. AbbVie Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. AbbVie Main Product
Table 102. AbbVie Recent Development
Table 103. Gilead Sciences Cancer Immunotherapies Corporation Information
Table 104. Gilead Sciences Corporation Information
Table 105. Gilead Sciences Cancer Immunotherapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Gilead Sciences Main Product
Table 107. Gilead Sciences Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Cancer Immunotherapies Distributors List
Table 111. Cancer Immunotherapies Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Cancer Immunotherapies Sales (K Units) Forecast by Type (2021-2026)
Table 116. Global Cancer Immunotherapies Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Cancer Immunotherapies Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Cancer Immunotherapies Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Cancer Immunotherapies Sales (K Units) Forecast by Application (2021-2026)
Table 120. Global Cancer Immunotherapies Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Cancer Immunotherapies Sales (K Units) Forecast by Region (2021-2026)
Table 122. Global Cancer Immunotherapies Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Cancer Immunotherapies Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Cancer Immunotherapies Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Cancer Immunotherapies
Figure 2. Global Cancer Immunotherapies Sales Market Share by Type: 2020 VS 2026
Figure 3. Monoclonal Antibodies (MABs) Product Picture
Figure 4. Cancer Vaccines Product Picture
Figure 5. Immunomodulators Product Picture
Figure 6. Adoptive Cell transfer Product Picture
Figure 7. Checkpoint Inhibitors Product Picture
Figure 8. Global Cancer Immunotherapies Consumption Market Share by Application: 2020 VS 2026
Figure 9. Breast Cancer
Figure 10. Leukemia
Figure 11. Lymphoma
Figure 12. Melanoma
Figure 13. Colorectal Cancer
Figure 14. Non-Small Cell Lung Cancer
Figure 15. Global Cancer Immunotherapies Market Size 2015-2026 (US$ Million)
Figure 16. Global Cancer Immunotherapies Sales Capacity (K Units) (2015-2026)
Figure 17. Global Cancer Immunotherapies Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Cancer Immunotherapies Sales Share by Manufacturers in 2020
Figure 19. Global Cancer Immunotherapies Revenue Share by Manufacturers in 2019
Figure 20. The Global 5 and 10 Largest Players: Market Share by Cancer Immunotherapies Revenue in 2019
Figure 21. Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Cancer Immunotherapies Sales Market Share by Region (2015-2020)
Figure 23. Global Cancer Immunotherapies Sales Market Share by Region in 2019
Figure 24. Global Cancer Immunotherapies Revenue Market Share by Region (2015-2020)
Figure 25. Global Cancer Immunotherapies Revenue Market Share by Region in 2019
Figure 26. North America Cancer Immunotherapies Sales Market Share by Country in 2019
Figure 27. North America Cancer Immunotherapies Revenue Market Share by Country in 2019
Figure 28. U.S. Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 29. U.S. Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Canada Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 31. Canada Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. Europe Cancer Immunotherapies Sales Market Share by Country in 2019
Figure 33. Europe Cancer Immunotherapies Revenue Market Share by Country in 2019
Figure 34. Germany Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 35. Germany Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. France Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 37. France Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. U.K. Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.K. Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Italy Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 41. Italy Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Russia Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 43. Russia Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Asia Pacific Cancer Immunotherapies Sales Market Share by Region in 2019
Figure 45. Asia Pacific Cancer Immunotherapies Revenue Market Share by Region in 2019
Figure 46. China Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 47. China Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Japan Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 49. Japan Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. South Korea Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 51. South Korea Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. India Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 53. India Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Australia Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 55. Australia Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Taiwan Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 57. Taiwan Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Indonesia Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 59. Indonesia Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Thailand Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 61. Thailand Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Malaysia Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 63. Malaysia Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Philippines Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 65. Philippines Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Vietnam Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 67. Vietnam Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Latin America Cancer Immunotherapies Sales Market Share by Country in 2019
Figure 69. Latin America Cancer Immunotherapies Revenue Market Share by Country in 2019
Figure 70. Mexico Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 71. Mexico Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Brazil Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 73. Brazil Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Argentina Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Middle East and Africa Cancer Immunotherapies Sales Market Share by Country in 2019
Figure 77. Middle East and Africa Cancer Immunotherapies Revenue Market Share by Country in 2019
Figure 78. Turkey Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Saudi Arabia Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 81. Saudi Arabia Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. U.A.E Cancer Immunotherapies Sales Growth Rate (2015-2020) (K Units)
Figure 83. U.A.E Cancer Immunotherapies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Sales Market Share of Cancer Immunotherapies by Type (2015-2020)
Figure 85. Sales Market Share of Cancer Immunotherapies by Type in 2019
Figure 86. Revenue Share of Cancer Immunotherapies by Type (2015-2020)
Figure 87. Revenue Market Share of Cancer Immunotherapies by Type in 2019
Figure 88. Global Cancer Immunotherapies Sales Growth by Type (2015-2020) (K Units)
Figure 89. Global Cancer Immunotherapies Sales Market Share by Application (2015-2020)
Figure 90. Global Cancer Immunotherapies Sales Market Share by Application in 2019
Figure 91. Global Revenue Share of Cancer Immunotherapies by Application (2015-2020)
Figure 92. Global Revenue Share of Cancer Immunotherapies by Application in 2020
Figure 93. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. ARMO BioSciences (Eli Lilly) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Price Trend of Key Raw Materials
Figure 106. Manufacturing Cost Structure of Cancer Immunotherapies
Figure 107. Manufacturing Process Analysis of Cancer Immunotherapies
Figure 108. Cancer Immunotherapies Industrial Chain Analysis
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Porter's Five Forces Analysis
Figure 112. North America Cancer Immunotherapies Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. North America Cancer Immunotherapies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Cancer Immunotherapies Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Cancer Immunotherapies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Cancer Immunotherapies Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Cancer Immunotherapies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Cancer Immunotherapies Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Cancer Immunotherapies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Cancer Immunotherapies Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Cancer Immunotherapies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
  • Global Melanoma Therapeutics Market Size, Status and Forecast 2021-2027
    Published: 19-Jan-2021        Price: US 3900 Onwards        Pages: 93
    Melanoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - Chemotherapy - Immunotherapy - T......
  • Global Small Molecule Targeted Cancer Therapy Market Growth (Status and Outlook) 2020-2025
    Published: 15-Jan-2021        Price: US 3660 Onwards        Pages: 116
    According to this study, over the next five years the Small Molecule Targeted Cancer Therapy market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Small Molecule Targeted Cancer Therapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Small ......
  • Global Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2021-2027
    Published: 12-Jan-2021        Price: US 3900 Onwards        Pages: 90
    Small Molecule Targeted Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Targeted Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - Monoclonal A......
  • Global T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027
    Published: 12-Jan-2021        Price: US 3900 Onwards        Pages: 99
    T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - CAR-T - TCR - TIL Therapies ......
  • Sezary Syndrome - Global Clinical Trials Review, H1, 2021
    Published: 08-Jan-2021        Price: US 2500 Onwards        Pages: 165
    Sezary Syndrome - Global Clinical Trials Review, H1, 2021 Summary GlobalData's clinical trial report, "Sezary Syndrome - Global Clinical Trials Review, H1, 2021" provides an overview of Sezary Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Sezary Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease cl......
  • Global T-Cell Immunotherapy Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 07-Jan-2021        Price: US 3500 Onwards        Pages: 119
    Based on the T-Cell Immunotherapy market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in det......
  • Global Actinic Keratosis Treatment Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 07-Jan-2021        Price: US 3500 Onwards        Pages: 106
    Based on the Actinic Keratosis Treatment market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed......
  • Global Cancer Immunomodulator Market Research Report 2021
    Published: 31-Dec-2020        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Method of Use:CoQ10 - Method of Use:Levamisole Coating Agent Segment by Application - Hospit......
  • Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2029
    Published: 30-Dec-2020        Price: US 10995 Onwards        Pages: 181
    Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2029 Summary Non-small cell lung cancer (NSCLC) is currently the most common cancer in the world and is the leading cause of cancer mortality in men and women. Of total lung cancer incident cases, approximately 85% are the NSCLC subtype. NSCLC patients are usually diagnosed in the later stages of the disease, resulting in a poor prognosis. Since the last global market forecast (2015-2025), there ha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs